Hamburg: FDA could have acted more aggressively with compounders

Testifying at a House hearing Tuesday, FDA Commissioner Dr. Margaret Hamburg admitted that her agency could have acted more aggressively against the New England Compounding Center, a pharmacy tied to a deadly meningitis outbreak last fall. She also repeated concerns about the FDA's lack of influence over these pharmacies, saying it needs greater authority to make compounders follow tighter standards of safety.